TEVA 7389 (Risedronate sodium 35 mg)

Pill imprint TEVA 7389 has been identified as Risedronate sodium 35 mg.

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substance Act (CSA).

Risedronate sodium

Imprint:

TEVA 7389

Strength:

35 mg

Color:

Orange

Shape:

Round

Availability:

Prescription only

Drug Class:

Bisphosphonates

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Teva Pharmaceuticals USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.